|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
|
Sep 26
|
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
|
|
May 15
|
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
|
|
Apr 19
|
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
|
|
Apr 18
|
Pharming Group announces the placement of €100 million convertible bonds due 2029
|
|
Apr 18
|
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
|